Final FIle_3D Printing.

Recommendations

Info

Expert's Views Empowering Other’s To Build With Life Allevi is building tools to design and engineer with life. Our 3D bioprinters and bioinks are used by leading researchers all around the world to find solutions to humanity’s most difficult problems - to cure disease, to test novel drugs, to eliminate the organ waiting list, to build with life. Founded in 2014, our mission is to make it easy to design and engineer 3D tissues. We created our desktop 3D bioprinter to be the most versatile, powerful and easy-to-use bioprinter on the market. Since our humble beginnings, we have grown to serve hundreds of labs in all corners of the world and have become leaders in the biofabrication revolution. At Allevi, the biggest challenge is definitely the symphony of things that need to work together to make the overall solution work. 3D printing is a mixture of robotics, software, and material science. For us we still use robotics and software but our added layer of complexity is that we print cells. And this is truly where we derive our specialty. We’ve learned a lot in the past to be able to print and pattern cells. The next step is really to get the biology to perform and working with biologist around the world is the best way to tackle this. In terms of the 3D printing industry, the globe is moving towards demands of more regional personalized products as well as thoughts around sustainability. In era where mass manufacturing has become mainstream, the new generations are more conscious of where products are bought, who makes them, and how do they benefit not only themselves but the community. I believe we will see 3D printing continue to take a greater and greater role in providing these more regionalized sustainable products for new market demands. 32
In terms of Allevi, medicine is also driving in a more personalized direction. Informed patients are understanding that tailored medication will drive more efficient and effective results for their treatments. This is particularly true when it comes to either more chronic or cancerous diseases. Therefore, 3D bioprinting will allow physicians to be able to print out patient’s disease tissue to study drugs to understand the personalized prognosis for the patient in a quick fashion. Likewise, physicians will also be able to in the future print personalized therapeutics from drugs to medical devices. The future of medicine is personalized and Allevi is excited to be catalyzing this new era. Ricky Solorzano CEO Allevi About the Author: Ricky Solorzano as the CEO of Allevi guides the vision, strategy, and day to day operation. He has been obsessed with tissue engineering for 8 years, created the rst desktop 3D bioprinter out of his dorm room, and has been a Forbes 30 under 30, Inc 30 under 30, and Business Insider 100: The Creators #65. 33
Page 1: www.mirrorreview.com March 2019 Sma
Page 5 and 6: CREDIT PAGE Publisher : Editor-in-C
Page 7: 18 3D Compare: The Leading Firm In
Page 11 and 12: Crafting Eco-friendly Materials To
Page 13 and 14: No matter where you are in your 3D
Page 16 and 17: Get Inspired, Stay Updated with all
Page 18 and 19: 3D Compare: The Leading Firm In On-
Page 20 and 21: ANYCUBIC: Making 3D Printers Precis
Page 22 and 23: DIGITIZE | DESIGN | SIMULATE MANUFA
Page 24 and 25: Filabot: Enhancing The 3D Printing
Page 26 and 27: JAMPT Corporation: Pioneering The R
Page 28 and 29: Smart Cars AI is transforming the a
Page 30: Smart Cars The Actual Autonomous Ca
Page 37 and 38: “ Leader with Great Self-learning
Page 39 and 40: proves that the present world is un

Final FIle_3D Printing.

Create successful ePaper yourself

Delete template?

Save as template?